MedPath

JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH & DEVELOPMET L.L.C.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

A Study of the Pharmacokinetics, Safety and Tolerability of Topiramate in Infants (Age 1-24 Months) With Refractory Partial-onset Seizures

Phase 1
Completed
Conditions
Seizures
First Posted Date
2005-10-05
Last Posted Date
2010-05-25
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
16
Registration Number
NCT00233012

A Study To Evaluate The Effect Of Topiramate On Clinical And Electrophysiological Parameters In Subjects With Diabetic Peripheral Polyneuropathy

Phase 2
Completed
Conditions
Diabetic Neuropathies
Diabetes Mellitus, Type 2
Polyneuropathies
Interventions
First Posted Date
2005-10-04
Last Posted Date
2011-06-08
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
72
Registration Number
NCT00231673

A Study of the Efficacy and Safety of Topiramate in the Treatment fo Obese, Type 2 Diabetic Patients Treated With Metformin

Phase 3
Completed
Conditions
Obesity
Diabetes Mellitus, Type 2
Diabetes Mellitus, Adult-Onset
First Posted Date
2005-10-04
Last Posted Date
2011-06-08
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
211
Registration Number
NCT00231660

A Study of the Safety and Efficacy of Topiramate in the Treatment of Obese, Type 2 Diabetes Patients on a Controlled Diet

Phase 3
Completed
Conditions
Obesity
Diabetes Mellitus, Type 2
Diabetes Mellitus, Adult-Onset
First Posted Date
2005-10-04
Last Posted Date
2011-06-08
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
541
Registration Number
NCT00231530

A Study of the Efficacy and Safety of Topiramate in Obese, Type 2 Diabetic Patients Inadequately Controlled on Sulfonylurea Therapy

Phase 3
Terminated
Conditions
Obesity
Diabetes Mellitus, Type 2
Diabetes Mellitus, Adult-Onset
First Posted Date
2005-10-04
Last Posted Date
2011-06-08
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
31
Registration Number
NCT00231634

A Study of Safety and Efficacy of Topiramate in Male Patients With Abdominal Obesity

Phase 2
Completed
Conditions
Obesity
First Posted Date
2005-10-04
Last Posted Date
2011-06-08
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
68
Registration Number
NCT00231608

A Study on Efficacy and Safety of Topiramate in Treatment of Obese Subjects With Dyslipidemia

Phase 3
Terminated
Conditions
Obesity
Hyperlipidemia
Hypertriglyceridemia
First Posted Date
2005-10-04
Last Posted Date
2011-06-08
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
179
Registration Number
NCT00231621

A Study on Efficacy and Safety of Topiramate OROS Controlled-Release in Obese, Type 2 Diabetic Subjects Managed With Diet or Metformin

Phase 2
Completed
Conditions
Obesity
Diabetes Mellitus, Type 2
Diabetes Mellitus, Adult-Onset
First Posted Date
2005-10-04
Last Posted Date
2011-06-08
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
113
Registration Number
NCT00231647

A Study of the Efficacy and Safety of Topiramate in the Prevention of Migraine

Phase 3
Completed
Conditions
Migraine
Common Migraine
Classic Migraine
Headache
First Posted Date
2005-10-04
Last Posted Date
2010-11-19
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
768
Registration Number
NCT00231595

A Study on Safety and Efficacy of Two Doses of Topiramate as Monotherapy in the Treatment of Newly Diagnosed or Recurrent Epilepsy

Phase 3
Completed
Conditions
Epilepsies, Partial
Epilepsy
Seizures
Epilepsy, Tonic-Clonic
Epilepsy, Generalized
First Posted Date
2005-10-04
Last Posted Date
2011-06-08
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
750
Registration Number
NCT00231556
© Copyright 2025. All Rights Reserved by MedPath